Literature DB >> 24144143

[The lymph nodes imprint for the diagnosis of lymphoid neoplasms].

Carolina Peniche-Alvarado1, Christian Omar Ramos-Peñafiel, Carlos Martínez-Murillo, Mónica Romero-Guadarrama, Irma Olarte-Carrillo, Etta Rozen-Fuller, Adolfo Martínez-Tovar, Juan Collazo-Jaloma, Carlos Alberto Mendoza-García.   

Abstract

BACKGROUND: lymphoma is the most frequent lymphoid neoplasm in our country. Its diagnosis is based on histopathological findings. The lymph node imprint has been used for more than 40 years. The aim was to establish the sensitivity, specificity, positive predictive value and negative predictive value of lymph node imprint and estimate the inter-observer rate.
METHODS: we did an observational, retrospective, prolective study, based on the lymph node imprint obtained by excisional biopsies over a period of 6 years.
RESULTS: the inclusion criteria was met on 199 samples, 27.1 % were considered as reactive (n = 54), 16.1 % Hodgkin lymphoma (n = 32), 40.2 % (n = 80) non-Hodgkin lymphoma and 16.6 % (n = 33) as metastatic carcinoma. Comparing with the final histopathology report, the sensitivity and specificity of lymph node imprint were 88 % (0.81-0.95) and 64 % (0.55-0.73) respectively, the positive predictive value was 67 % (0.59-0.76) and the negative predictive value was 86 % (0.79-0.94). The interobserver kappa index was 0.467.
CONCLUSIONS: the lymph node imprint remains as a useful tool for the diagnosis of lymphoid neoplasm. The agreement between observers was acceptable.

Entities:  

Keywords:  excisión del linfoma; ganglio linfático; lymph node excision; lymphatic metastasis; lymphoma; metástasis linfática; predictive value of tests; valor predictivo de las pruebas

Mesh:

Year:  2013        PMID: 24144143

Source DB:  PubMed          Journal:  Rev Med Inst Mex Seguro Soc        ISSN: 0443-5117


  1 in total

1.  ETIOPATHOGENIC, EPIDEMIOLOGIC AND CLINICAL-THERAPEUTIC COMPARISON OF NON-HODGKIN'S LYMPHOMA AND KAPOSI'S SARCOMA.

Authors:  Andy Petroianu; Luiz Ronaldo Alberti; Vanessa Lacerda Orsi; Flávia Costa Teixeira Viana; Carolina Braga Moura
Journal:  Arq Bras Cir Dig       Date:  2020-11-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.